Age [y] | 62.1 ± 4.1 (53–68)* |
Weight [kg] | 88.8 ± 11.4 (65–109)* |
Height [cm] | 177.4 ± 6.1 (170–191)* |
PSA [ng/mL] | 9.4 ± 6.3 (3.5–25.5)* |
Injected [18F]DCFPyL activity [MBq] | 312.4 ± 15.9 (280.8–348.2)* |
Histology—n(%) | |
Adenocarcinoma | 15 (100) |
pT Stage—n(%) | |
 T2c | 7 (46.7) |
 T3a | 7 (46.7) |
 T3b | 1 (6.7) |
pN Stage—n(%) | |
 N0 | 15 (100) |
 N1 | 0 (0) |
 NX | 0 (0) |
pM Stage—n(%) | |
 M0 | 15 (100) |
 M1 | 0 (0) |
 MX | 0 (0) |
Gleason score of DIL—n(%) | |
 6 (3 + 3) | 1 (6.7) |
 7 (3 + 4) | 6 (40.0) |
 7 (4 + 3) | 5 (33.3) |
9 (5 + 4) | 3 (20.0) |